CFM Pharma

Description

CFM Pharma is a Dutch clinical-stage biotech developing VANADIS®, a platform for tissue protection and repair in acute injury, with applications including cardiology, burns, and trauma.

Related

• BioPorto A/SBioPorto A/S develops diagnostic biomarker tests and kits; provides the NGAL test and ELISA kits to clinicians and researchers for early…
• KerecisKerecis makes medical devices based on fish skin and fatty acids, aimed at soft tissue regeneration and treatment of wounds, burns, and…
• CUTISSCUTISS develops personalized bioengineered skin tissue therapeutics and an automated production platform for patients needing skin surgery,…
• LUMA VisionLUMA Vision develops ultrasound-based cardiac imaging hardware, software and machine-learning products, including an imaging catheter…
• Ysios CapitalYsios Capital invests in biotech ventures, building portfolios of innovative therapeutic drug companies and supporting development of…
• Allterum TherapeuticsAllterum Therapeutics develops CD127-targeted antibody therapies for relapsed leukemia, acute lymphoblastic leukemia, lymphomas, other…
• OsivaxOsivax develops vaccines using its oligoDOM platform to elicit T-cell and B-cell immunity, producing clinical-stage vaccine candidates…
• Hansa BiopharmaHansa Biopharma develops enzyme-based immunomodulatory therapies that cleave pathogenic IgG antibodies for use in rare immunologic…
• Fraunhofer Institute for Interfacial Engineering and BiotechnologyFraunhofer IGB creates and expands biotech and engineering methods.
• Strand AIStrand AI develops Lattice, a research-use model that predicts spatial protein-marker maps from routine H&E tissue slides, primarily for…
• Auxilium BiotechnologiesAuxilium Biotechnologies develop bioprinting systems and implantable medical devices to treat traumatic peripheral nerve injury and enable…
• Altos LabsAltos Labs researches cellular rejuvenation to restore cell health and resilience, developing therapies and computational tools aimed at…